How AI can improve drug development probability assessments
Unlock the Power of AI for Drug Development Success
When it comes to reducing risk and elevating decision-making in drug development, artificial intelligence (AI) is one of the tools to transform both. In this guide, learn about:
- The use and value of the probability of technical and regulatory success (PTRS) assessments
- Current approaches and challenges in calculating PTRS
- Where AI can improve PTRS assessments
- The benefits of accurate, AI-driven PTRS assessments in de-risking clinical development